These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3025102)

  • 1. Anti-delta antibody in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia.
    Ashraf SJ; Arya SC; Parande CM; Sahay R; Ageel AR
    Infection; 1986; 14(5):250-1. PubMed ID: 3025102
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Ozyilkan E; Ozyilkan O; Firat D; Telatar H
    Cancer; 1994 Apr; 73(7):2002-3. PubMed ID: 8137230
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B and delta markers in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia.
    Arya SC; Ashraf SJ; Parande CM; Tobeiqi MS; Ageel AR
    APMIS Suppl; 1988; 3():30-4. PubMed ID: 2846019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sero-epidemiology of hepatitis delta virus infection in Somalia.
    Aceti A; Paparo BS; Celestino D; Pennica A; Caferro M; Grilli A; Sebastiani A; Mohamud OM; Abdirahman M; Bile K
    Trans R Soc Trop Med Hyg; 1989; 83(3):399-400. PubMed ID: 2617589
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 7. Delta agent and the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
    Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Katayama K; Fusamoto H; Kamada T
    Dig Dis Sci; 1992 Jan; 37(1):65-72. PubMed ID: 1309450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral hepatitis markers in patients on haemodialysis in a hyperendemic area.
    Ashraf SJ; Arya SC; Parande CM
    J Med Virol; 1986 May; 19(1):41-6. PubMed ID: 3009704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-delta antibody in various HBsAg positive Argentine populations.
    Fay O; Tanno H; Palazzi J; Gatti H
    Prog Clin Biol Res; 1987; 234():517-8. PubMed ID: 3628422
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia.
    al Karawi MA; Shariq S; el Shiekh Mohamed AR; Saeed AA; Ahmed AM
    J Gastroenterol Hepatol; 1992; 7(3):237-9. PubMed ID: 1319221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serological markers for hepatitis B virus and delta antibody in Brazilian male homosexuals].
    Ferraz ML; Vilela MP; Silva AE; Paiva ER
    Rev Paul Med; 1985; 103(5):228-30. PubMed ID: 3832313
    [No Abstract]   [Full Text] [Related]  

  • 14. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?
    Kew MC; Dusheiko GM; Hadziyannis SJ; Patterson A
    Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1727. PubMed ID: 6329398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical remarks regarding the analysis of markers of acute viral hepatitis].
    Oszczak A; Maciejewska E
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):283-4. PubMed ID: 1332002
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.
    Karayiannis P; Fowler MJ; Lok AS; Greenfield C; Monjardino J; Thomas HC
    J Hepatol; 1985; 1(2):99-106. PubMed ID: 2997321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on delta virus infection and its clinical impact in Iran.
    Rezvan H; Forouzandeh B; Taroyan S; Fadaiee S; Azordegan F
    Infection; 1990; 18(1):26-8. PubMed ID: 2155876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delta infection in children with chronic hepatitis B].
    Nisevich NI; Kaganov BS; Guseva LN; Syr'eva TN; Konev VA
    Pediatriia; 1988; (6):11-4. PubMed ID: 3186398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
    de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
    Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
    [No Abstract]   [Full Text] [Related]  

  • 20. Endemic hepatitis delta virus infection in a Greek community.
    Hadziyannis SJ; Hatzakis A; Papaioannou C; Anastassakos C; Vassiliadis E
    Prog Clin Biol Res; 1987; 234():181-202. PubMed ID: 2442775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.